Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial

European Journal of Anaesthesiology

Volumn 34, Issue 9, 2017, Pages 609-616

  Nemes, Réka ^a   Fülesdi, Béla ^a,c   Pongrácz, Adrienn ^a   Asztalos, László ^a   Szabó Maák, Zoltán ^a   Lengyel, Szabolcs ^b   Tassonyi, Edömér ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c OUTCOMES RESEARCH CONSORTIUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; FENTANYL; MIDAZOLAM; NEOSTIGMINE; PLACEBO; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; ANDROSTANE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ABDOMINAL SURGERY; ACCELEROMETER; ACCELEROMETRY; ACCELEROMYOGRAPHY; ADULT; ANESTHESIST; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTRIC PERIPHERAL NERVE STIMULATOR; EXTUBATION; FEMALE; GENERAL ANESTHESIA; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE RELAXATION; MYOGRAPHY; NEUROLOGICAL DIAGNOSTIC DEVICE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR MONITORING; NEUROMUSCULAR TRANSMISSION; ODDS RATIO; OXYGEN THERAPY; PARALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE RESIDUAL NEUROMUSCULAR BLOCK; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; RESPIRATION DEPRESSION; TRACHEA; UNIVERSITY HOSPITAL; CHEMICALLY INDUCED; DELAYED EMERGENCE FROM ANESTHESIA; DRUG EFFECT; INCIDENCE; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

ADULT; ANDROSTANOLS; DELAYED EMERGENCE FROM ANESTHESIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR MONITORING; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES;

EID: 85026903375     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000585     Document Type: Article

References (25)

1. Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013-1022.
2. Caldwell JE. Clinical limitations of acetylcholinesterase antagonists. J Crit Care 2009; 24:21-28.
3. Naguib M, Kopman AF, Lien CA, et al. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111:110-119.
4. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002; 96:45-50.
5. Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009; 103:115-129.
6. Kim KS, Cheong MA, Lee HJ, et al. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004; 99:1080-1085.
7. McIntyre JA, Castaner J. Sugammadex sodium. Drugs Fut 2005; 30: 780-784.
8. Suy K, Morias K, Cammu G, et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106:283-288.
9. Gijsenbergh F, Ramael S, Houwing N, et al. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103:695-703.
10. Tassonyi E, Pongrácz A, Nemes R, et al. Reversal of pipecuronium-Induced moderate neuromuscular block with sugammadex in the presence of a sevoflurane anesthetic: a randomized trial. Anesth Analg 2015; 121: 373-380.
11. Pongrácz A, Szatmári S, Nemes R, et al. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-offour stimulation. Anesthesiology 2013; 119:36-42.
12. Hayes AH, Mirakhur RK, Breslin DS, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anesthesia 2001; 56:312-318.
13. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117:345-351.
14. Morita T, Tsukagoshi H, Sugaya T, et al. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. Anesth Analg 1995; 80:1175-1180.
15. Fuchs-Buder T, Claudius C, Skofgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808.
16. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005; 95:622-626.
17. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120-128.
18. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002; 359:515-519.
19. Hammer Ø, Harper DA, Ryan PD. PAST: paleontological statistics software package for education and data analysis. Palaeontol Electronica 2001; 4:9.
20. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62:806-809.
21. Esteves S, Martins M, Barros F, et al. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. Eur J Anaesthesiol 2013; 30:243-249.
22. Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol 2014; 31:423-429.
23. Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology 2014; 121:959-968.
24. Fortier LP, McKeen D, Turner K, et al. The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg 2015; 121:366-372.
25. Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth 2015; 115:743-751.